Filing Details
- Accession Number:
- 0001127602-23-029727
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-15 17:07:18
- Reporting Period:
- 2023-12-13
- Accepted Time:
- 2023-12-15 17:07:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1830214 | Ginkgo Bioworks Holdings Inc. | DNA | Biological Products, (No Disgnostic Substances) (2836) | 872652913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1882756 | Barry Canton | C/O Ginkgo Bioworks Holdings 27 Drydock Avenue Boston MA 02210 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2023-12-13 | 36,829 | $1.34 | 12,413,025 | No | 4 | S | Indirect | By Spouse |
| Class A Common Stock | Disposition | 2023-12-14 | 821 | $1.48 | 12,412,204 | No | 4 | S | Indirect | By Spouse |
| Class A Common Stock | Disposition | 2023-12-14 | 37,650 | $1.63 | 12,412,194 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Direct |
Footnotes
- The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.285 to $1.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Billionaire Hedge Funds
